Thyroid Dysfunction and Its Association with Glycemic Control in Patients with Type 2 Diabetes Mellitus (T2DM): A Systematic Review and Meta-Analysis
Keywords:
Internal Medicine, Type 2 Diabetes Mellitus, thyroid dysfunction, glycemic control, Endocrine disorderAbstract
Background: Diabetes mellitus (DM) is characterized by metabolic anomalies, such as hyperglycemia, resulting from pancreatic β-cell dysfunction. In this context, thyroid dysfunction is the second most prevalent endocrine disorder after DM, and the interaction with glycemic control in type 2 diabetes mellitus (T2DM) remains a topic of debate. Therefore, this meta-analysis aimed to evaluate the impact of thyroid dysfunction on glycemic control in T2DM patients. Methods: A systematic literature search was conducted using ScienceDirect, the Cochrane Library, and PubMed up to December 8, 2024, under PRISMA guidelines. Research evaluating the effect of thyroid dysfunction on glycemic control in T2DM was included, with Glycated hemoglobin (HbA1c) levels as the primary outcome measure. Furthermore, research lacking relevant outcome data, full-text availability, or appropriate design was excluded. Data extraction and quality assessment were performed collaboratively, using the STROBE checklist. Meta-analysis was conducted using Review Manager 5.4, with mean difference (MD) and 95% confidence intervals (CI) as the effect size. Random-effects models were used to account for anticipated clinical heterogeneity, assessed by Higgins' I-squared (I²) statistic. Results: The initial search identified 1,397 research studies, with only 3 papers meeting the inclusion criteria. A pooled analysis reported a significant increase in HbA1c levels in T2DM patients with thyroid dysfunction (MD: 1.94, 95% CI: 0.73 - 3.14; p < 0.000001) with high heterogeneity (I² = 98%). Conclusion: Thyroid dysfunction was prevalent in T2DM patients and was associated with poorer glycemic control. Routine thyroid function assessment could also be integrated into T2DM management to optimize metabolic outcomes.References
Chutia, Happy, Bhattacharyya H, Ruram AA, Bora K, Chakraborty M. Evaluation of thy-roid function in type 2 diabetes in north-eastern part of India: A hospital-based study. Journal of Family Medicine and Primary Care. 2018;7(4):752-5.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabe-tes Care. 2010; 33(1):62-9.
da Silva LA, Wouk J, Weber VM. Relation between diabetes mellitus, thyroid hormones and caffeine. Journal of Applied Pharmaceutical Science. 2017;7(3): 2017.
Makandar A, Sonagra AD, Shafi N. Study of thyroid function in type 2 diabetic and non-diabetic population. International Journal of Medical Sciences and Public Health. 2015;4(6).
Papazafiropoulou A, Sotiropoulos A, Kokolaki A, Kardara M. Prevalence of thyroid dys-function among Greek type 2 diabetic patients attending an outpatient clinic. Journal of Clinical Medical Research. 2010;2(2):75-8.
Ahmed A, Mohamed S, Elmadi SA. Assessment of thyroid dysfunctions in type 2 diabetes mellitus patients in Surman, Western-Libya. International Journal of Clinical and Exper-imental Research. 2017;3(31):1-4.
Brenta G, Celi FS, Pisarey M, Schnitman M. Acute thyroid hormone withdrawal in athyre-otic patients results in a state of insulin resistance. Thyroid. 2009;19(6):665-9.
Dehaki MG, Amouzegar A, Delshad H, Mehrabi Y, Tohidi M. Thyroid dysfunction in pa-tients with impaired glucose metabolism: 11-year follow-up from the Tehran thyroid study. PLoS One. 2017;12(10):0184808.
Han C, He X, Xia X, Li Y, Shi X, Shan Z, Teng W. Subclinical hypothyroidism and type 2 dia-betes: A systematic review and meta-analysis. PLoS One. 2015;10(8):135233.
Cho JH, Kim HJ, Lee JH, Park IR, Moon JS, Yoon JS. Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus. Ko-rean Journal of Internal Medicine. 2016;31(4):703-11.
Gronich N, Deftereos SN, Lavi I, Persidis AS. Hypothyroidism is a risk factor for new-onset diabetes: A cohort study. Diabetes Care.2015;38(9):1657-64.
Iwakura H, Takagi T, Inaba H, Doi A, Ueda Y. Thyroid function, glycemic control, and dia-betic nephropathy in patients with type 2 diabetes over 24 months: prospective observa-tional study. BMC Endocrine Disorders. 2023;23:146.
Palma CCS, Pavesi M, Nogueira VG, Clemente EL. Prevalence of thyroid dysfunction in patients with diabetes mellitus. Diabetology & Metabolic Syndrome. 2013;5:58.
Peters KE, Chubb SA, Bruce DG, Davis WA, Davis T M. Prevalence and incidence of thy-roid dysfunction in type 1 diabetes, type 2 diabetes and latent autoimmune diabetes of adults: The Fremantle Diabetes Study Phase II. Clinical Endocrinology. 2020;92(4):373-82.
Ferrannini E, Iervasi G, Cobb J, Ndreu R. Insulin resistance and normal thyroid hormone levels: prospective study and metabolomic analysis. American Journal of Physiology, En-docrinology, and Metabolism. 2017;312(5):429-36.
Park SY, Park SE, Jung SW, Jin HS, Park IB, Ahn S. V. Free triiodothyronine/free thyroxine ratio rather than thyrotropin is more associated with metabolic parameters in healthy euthyroid adult subjects. Clinical Endocrinology. 2017;87(1):87-96.
Park HT, Cho GJ, Ahn KH, Shin JH, Hong SC, Kim T, Hur JY. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas. 2009;62(3):301-5.
Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F. Serum free thyroxine concentra-tion is associated with metabolic syndrome in euthyroid subjects. Thyroid. 2014;24(11):1566-74.
Santini F, Marzulio P, Rotondi M, Ceccarini G, Pagano L, Ippolito S, Chiovato L. Mecha-nisms in endocrinology: the crosstalk between thyroid gland and adipose tissue: signal integration in health and disease. European Journal of Endocrinology. 2014; 171(4):137-52.
Denroche HC, Huynh FK, Kieffer TJ. The role of leptin in glucose homeostasis. Journal of Diabetes Investigation. 2012;3(2):115-29.
Tian L, Song Y, Xing M, Zhang W, Ning G, Li X. A novel role for thyroid-stimulating hor-mone: up-regulation of hepatic 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase ex-pression through the cyclic adenosine monophosphate/protein kinase A/cyclic adenosine monophosphate-responsive element binding protein. Hepatology. 2010;52(4):1401-9.
Wang T, Xu J, Bo T, Zhou X, Jiang X, Gao L, Zhao J. Decreased fasting blood glucose is as-sociated with impaired hepatic glucose production in thyroid-stimulating hormone re-ceptor knockout mice. Endocrinology Journal. 2013; 60(8):941-50.
Al-Hamodi Z, Al-Habori M, Al-Meeri A, Saif-Ali R. Association of adipokines, lep-tin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus. Diabetology & Metabolic Syndrome. 2014; 6:99.
Jun JE, Jin S-M, Jee J. H, Bae JC, Hur K. Y, Lee M.-K. TSH increment and the risk of inci-dent type 2 diabetes mellitus in euthyroid subjects. Endocrine. 2017;55(3):944-53.
Jun JE, Jee JH, Bae JC, Jin S-M, Hur KY, Lee MK. Association between changes in thyroid hormones and incident type 2 diabetes: A seven-year longitudinal study. Thyroid. 2017;27(1):29-38.
Lin Y, Sun Z. Thyroid hormone potentiates insulin signaling and attenuates hyperglycemia and insulin resistance in a mouse model of type 2 diabetes. British Journal of Pharma-cology. 2011;162(3):597-610.
Yavuz DG, Yuksel M, Deyneli O, Ozen Y, Aydin H, Akalin S. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients. Clinical Endocrinology. 2004;61(4):515-21.
Gu Y, Li H, Bao X, et al. The relationship between thyroid function and the prevalence of type 2 diabetes mellitus in euthyroid subjects. Journal of Endocrinology and Metabolism. 2017;102(2):434-42.
Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS. Cellular and mo-lecular basis of deiodinase-regulated thyroid hormone signaling. Endocrinology Reviews. 2008;29(7):898-938.
Kvetny J, Wilms J, Pedersen PL, Larsen J. Subclinical hypothyroidism affects mitochondri-al function. Hormone and Metabolic Research. 2010;42(5):324-7.
Handisurya A, Pacini G, Tura A, Gessi A. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH). Clinical En-docrinology. 2008;69(6):963-696.
Lambadiari V, Mitrou P, Maratou E, Raptis AE. Thyroid hormones are positively associat-ed with insulin resistance early in the development of type 2 diabetes. Endocrine. 2011;39(1):28-32.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Medica Indonesiana
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
